{
    "ticker": "BETR",
    "name": "Better Therapeutics, Inc.",
    "description": "Better Therapeutics, Inc. is a biotechnology company focused on developing prescription digital therapeutics to treat chronic diseases. Founded in 2015, the company leverages advanced technology and behavioral science to create innovative solutions that help patients manage their health conditions effectively. Better Therapeutics specializes in the treatment of cardiometabolic diseases, with a primary focus on diabetes and obesity. Their flagship product, a digital therapeutic designed for the management of Type 2 diabetes, combines personalized behavioral therapy with data-driven insights to empower patients in making healthier lifestyle choices. This innovative approach not only aims to improve clinical outcomes but also enhances the overall quality of life for patients. Better Therapeutics is at the forefront of the digital health revolution, striving to bridge the gap between technology and traditional healthcare by providing scalable, evidence-based interventions. The company's mission is to transform the way chronic diseases are treated by integrating therapeutic solutions into everyday life, ultimately reducing the burden of these conditions on individuals and healthcare systems alike.",
    "industry": [
        "Biotechnology",
        "Digital Health"
    ],
    "headquarters": "San Francisco, California, USA",
    "founded": "2015",
    "website": "https://www.bettertx.com",
    "ceo": "Kevin C. O'Connor",
    "social_media": {
        "twitter": "https://twitter.com/BetterTx",
        "linkedin": "https://www.linkedin.com/company/better-therapeutics"
    },
    "investor_relations": "https://investors.bettertx.com",
    "key_executives": [
        {
            "name": "Kevin C. O'Connor",
            "position": "CEO"
        },
        {
            "name": "Catherine O'Connor",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Digital Therapeutics",
            "products": [
                "Diabetes Management Program"
            ]
        }
    ],
    "seo": {
        "meta_title": "Better Therapeutics, Inc. | Prescription Digital Therapeutics for Chronic Disease",
        "meta_description": "Explore Better Therapeutics, Inc., a leader in developing prescription digital therapeutics focused on managing chronic diseases like diabetes and obesity.",
        "keywords": [
            "Better Therapeutics",
            "Digital Health",
            "Chronic Disease Management",
            "Diabetes",
            "Digital Therapeutics"
        ]
    },
    "faq": [
        {
            "question": "What does Better Therapeutics focus on?",
            "answer": "Better Therapeutics focuses on developing prescription digital therapeutics for chronic diseases, particularly diabetes and obesity."
        },
        {
            "question": "Who is the CEO of Better Therapeutics?",
            "answer": "Kevin C. O'Connor is the CEO of Better Therapeutics, Inc."
        },
        {
            "question": "Where is Better Therapeutics headquartered?",
            "answer": "Better Therapeutics is headquartered in San Francisco, California, USA."
        },
        {
            "question": "What is Better Therapeutics' main product?",
            "answer": "Better Therapeutics' main product is a digital therapeutic designed for the management of Type 2 diabetes."
        },
        {
            "question": "When was Better Therapeutics founded?",
            "answer": "Better Therapeutics was founded in 2015."
        }
    ],
    "competitors": [
        "NVCR",
        "PTCT",
        "ABMD"
    ],
    "related_stocks": [
        "AMGN",
        "VRTX",
        "GILD",
        "REGN"
    ]
}